Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Emily DiMango, MD
CONTACT
Charles Emala, MD
CONTACT
Lead
Emily DiMango, MD
With
The study is based on preclinical evidence that active ginger components and their metabolites can relax airway smooth muscle and reduce lung inflammation, potentially through inhibition of phospholipase C (PLC), which is involved in both airway constriction and inflammatory cytokine release. The trial will evaluate whether oral ginger improves airway hyperresponsiveness, measured by tolerance to inhaled methacholine, and reduces markers of inflammation in adults with asthma. It will also assess the bioavailability and pharmacokinetics of active ginger metabolites. The selected ginger formulation and doses of 2-3 g/day were chosen based on prior human studies demonstrating generally good tolerability, with mostly mild gastrointestinal side effects. Because of limited evidence that ginger may affect platelet aggregation, participants taking anticoagulant medications will be excluded.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
